Thackray Helen M.
SEC CIK 1589725 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Chief R, D Off | 377.3K | $175.8K | $215.2K | 14 | 2021-12-14 | 2025-03-31 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Thackray Helen M. made no open-market trades at BCRX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | 2025-03-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | F - Tax | $7.50 | -7,525 | 377.3K | -2% | -$56.4K | |
| D | 2024-12-23 | 2024-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | A - Grant | $0.00 | +126.0K | 390.9K | +48% | $0 |
| D | 2024-12-23 | 2024-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | F - Tax | $7.39 | -6,096 | 384.8K | -2% | -$45.0K |
| 2024-12-17 | 2024-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | F - Tax | $7.53 | -7,150 | 265.0K | -3% | -$53.8K | |
| 2024-05-15 | 2024-05-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | P - Purchase | $5.86 | +30.0K | 272.1K | +12% | +$175.8K | |
| 2024-04-02 | 2024-03-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | F - Tax | $5.08 | -7,525 | 242.1K | -3% | -$38.2K | |
| 2023-12-20 | 2023-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | F - Tax | $6.05 | -5,580 | 249.7K | -2% | -$33.8K | |
| D | 2023-12-18 | 2023-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | F - Tax | $6.43 | -3,031 | 255.2K | -1% | -$19.5K |
| D | 2023-12-18 | 2023-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | A - Grant | $0.00 | +51.0K | 258.3K | +25% | $0 |
| 2023-04-05 | 2023-04-03 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | S - Sale | $8.29 | -7,000 | 207.3K | -3% | -$58.0K | |
| D | 2022-12-21 | 2022-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | A - Grant | $0.00 | +81.0K | 214.3K | +61% | $0 |
| 2022-12-19 | 2022-12-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | S - Sale | $10.89 | -3,125 | 133.3K | -2% | -$34.0K | |
| 2022-04-04 | 2022-04-01 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | S - Sale | $16.20 | -7,600 | 136.4K | -5% | -$123.1K | |
| D | 2021-12-16 | 2021-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M. | Chief R, D Off | A - Grant | $0.00 | +44.0K | 144.0K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations